Gene transfer

LE WE PMID CA

Gene transfer

994

Gentransfer

Adenosine deaminase deficiency

Adenovirus

Atadenovirus

BAC YAC artificial chromosome

Biomembranes (BASKET)

Cloning (Whole organism)

DNA Vaccine

Duchenne s muscular dystrophy

Exon skipping

Eye (Pharmacology)

Gene transfer

Genetics (Transposon)

Hemoglobinopathy

Imaging (Molecular)

Immunodeficiency (Inherited)

Kidney (Neoplasm)

Laboratory animal (Pig)

Liver (Fibrosis)

MGMT

Morpholino

Nanomedicine

Neoplasia (Tumor biology and immunology)

Neurodegeneration

O6 alkylguanine DNA alkyltransferase

Oxygen (Hypoxia)

Radiation therapy

Redox (BASKET)

Regeneration of tissues and other biologic structures

RNA (MicroRNA)

RNA (Splicing)

RPE65

Splicing

Synthetic biology

Ultrasound (Toxicity and therapeutic use)

Wiskott Aldrich syndrome

Xenobiotics

1999 1	Herpes simplex virus vectors for gene therapy in Parkinson's disease and other diseases of the nervous system. [10703493] J R Soc Med 92(11): 566-70 (1999)
1997 2	Optimal techniques for arterial gene transfer. [9415283] Cardiovasc Res 35(3): 391-404 (1997)
2006 3	Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. [16507881] Pharmacol Rev 58(1): 32-45 (2006)
2000 4	Design of retroviral vectors and helper cells for gene therapy. [11121508] Pharmacol Rev 52(4): 493-511 (2000)
2005 5	Baculovirus as a highly efficient expression vector in insect and mammalian cells. [15780188] Acta Pharmacol Sin 26(4): 405-16 (2005)
2009 6	Herpes vector-mediated gene transfer in the treatment of chronic pain. [18841093] Mol Ther 17(1): 13-8 (2009)
2008 7	Recombinant adeno-associated virus transduction and integration. [18500252] Mol Ther 16(7): 1189-99 (2008)
2008 8	Gene delivery to the nervous system. [18362921] Mol Ther 16(4): 640-6 (2008)
2007 9	Advances in preclinical investigation of prostate cancer gene therapy. [17457317] Mol Ther 15(6): 1053-64 (2007)
2009 10	DNA as therapeutics; an update. [20502565] Indian J Pharm Sci 71(5): 488-98 (2009)
2008 11	Nano-vectors for efficient liver specific gene transfer. [18488414] Int J Nanomedicine 3(1): 31-49 (2008)
2007 12	Virus-mediated gene transfer to induce therapeutic angiogenesis: where do we stand? [18203421] Int J Nanomedicine 2(4): 527-40 (2007)
2007 13	Layered double hydroxide nanoparticles as cellular delivery vectors of supercoiled plasmid DNA. [17722544] Int J Nanomedicine 2(2): 163-74 (2007)
2000 14	Update on adenovirus and its vectors. [11038369] J Gen Virol 81(Pt 11): 2573-604 (2000)
1983 15	Cloning vectors derived from animal viruses. [6300283] J Gen Virol 64 (Pt 2)(-): 255-66 (1983)
2010 16	Herpesvirus vectors for therapy of brain tumors. [20811578] Open Virol J 4(-): 103-8 (2010)
2004 17	Ovine atadenovirus: a review of its biology, biosafety profile and application as a gene delivery vector. [15061773] Immunol Cell Biol 82(2): 189-95 (2004)
2007 18	Potential of helper-dependent adenoviral vectors in modulating airway innate immunity. [17484801] Cell Mol Immunol 4(2): 81-9 (2007)
2007 19	BAC to immunology--bacterial artificial chromosome-mediated transgenesis for targeting of immune cells. [17437533] Immunology 121(3): 308-13 (2007)
2009 20	Use of HIV as a gene transfer vector. [19936329] Acta Biochim Pol 56(4): 531-95 (2009)
2005 21	Adeno-associated virus vector-mediated gene delivery to the vasculature and kidney. [15940344] Acta Biochim Pol 52(2): 293-9 (2005)
2004 22	Production of functional transgenic mice by DNA pronuclear microinjection. [15094822] Acta Biochim Pol 51(1): 9-31 (2004)
2006 23	Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors. [16541123] Cell Res 16(3): 241-59 (2006)
2000 24	Gene transfer into chicken embryos by retrovirus vectors. [10910127] Dev Growth Differ 42(3): 213-8 (2000)
2000 25	Application of efficient and specific gene transfer systems and organ culture techniques for the elucidation of mechanisms of epithelial-mesenchymal interaction in the developing gut. [10910126] Dev Growth Differ 42(3): 207-11 (2000)
2009 26	Progress and prospects: the design and production of plasmid vectors. [19129858] Gene Ther 16(2): 165-71 (2009)
2008 27	Manufacturing and characterizing AAV-based vectors for use in clinical studies. [18418418] Gene Ther 15(11): 840-8 (2008)
2008 28	AAV-mediated gene therapy for retinal disorders: from mouse to man. [18418417] Gene Ther 15(11): 849-57 (2008)
2008 29	Clinical gene therapy using recombinant adeno-associated virus vectors. [18418415] Gene Ther 15(11): 858-63 (2008)
2008 30	AAV vectors for RNA-based modulation of gene expression. [18418414] Gene Ther 15(11): 864-9 (2008)
2008 31	Toward exascale production of recombinant adeno-associated virus for gene transfer applications. [18401433] Gene Ther 15(11): 823-30 (2008)
2008 32	Potential of AAV vectors in the treatment of metabolic disease. [18401432] Gene Ther 15(11): 831-9 (2008)
2008 33	Adeno-associated virus integration: virus versus vector. [18401436] Gene Ther 15(11): 817-22 (2008)
2008 34	Strategies for manufacturing recombinant adeno-associated virus vectors for gene therapy applications exploiting baculovirus technology. [18632744] Brief Funct Genomic Proteomic 7(4): 303-11 (2008)
2007 35	Animal transgenesis: state of the art and applications. [17272861] J Appl Genet 48(1): 47-61 (2007)
2007 36	Transformation of plasmid DNA into E. coli using the heat shock method. [18997900] J Vis Exp -(6): 253 (2007)
2006 37	Gene-gun transfection of hippocampal neurons. [18704184] J Vis Exp -(1): 121 (2006)
1999 38	HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications. [10933055] Neoplasia 1(5): 402-16 (1999)
1999 39	HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis. [10933054] Neoplasia 1(5): 387-401 (1999)
2009 40	Murine bone marrow-derived mesenchymal stem cells as vehicles for interleukin-12 gene delivery into Ewing sarcoma tumors. [19051291] Cancer 115(1): 13-22 (2009)
2002 41	Adenoviral gene therapy. [11854546] Oncologist 7(1): 46-59 (2002)
2008 42	Clinical relevance of the homologous recombination machinery in cancer therapy. [17953711] Cancer Sci 99(2): 187-94 (2008)
2006 43	Non-viral vectors for cancer therapy. [16630130] Cancer Sci 97(5): 348-54 (2006)
2001 44	Adeno-associated virus for cancer gene therapy. [11522617] Cancer Res 61(17): 6313-21 (2001)
2005 45	Vector-mediated cancer gene therapy: an overview. [15908802] Cancer Biol Ther 4(5): 512-7 (2005)
2009 46	The 'timely' development of Rexin-G: first targeted injectable gene vector (review). [19578735] Int J Oncol 35(2): 229-38 (2009)
2006 47	Pathotropic nanoparticles for cancer gene therapy Rexin-G IV: three-year clinical experience. [17016635] Int J Oncol 29(5): 1053-64 (2006)
2009 48	Armed replicating adenoviruses for cancer virotherapy. [19197323] Cancer Gene Ther 16(6): 473-88 (2009)
2006 49	Transductional targeting of adenovirus vectors for gene therapy. [16439993] Cancer Gene Ther 13(9): 830-44 (2006)
2005 50	Adeno-associated virus vectors: potential applications for cancer gene therapy. [15962012] Cancer Gene Ther 12(12): 913-25 (2005)
2002 51	Adenoviral vectors: systemic delivery and tumor targeting. [12522442] Cancer Gene Ther 9(12): 1036-42 (2002)
2002 52	Selectively replicating viral vectors. [12522438] Cancer Gene Ther 9(12): 987-1000 (2002)
2002 53	Intravascular adenoviral agents in cancer patients: lessons from clinical trials. [12522437] Cancer Gene Ther 9(12): 979-86 (2002)
2002 54	RNA viruses as virotherapy agents. [12522435] Cancer Gene Ther 9(12): 961-6 (2002)
2002 55	Virotherapy for cancer: current status, hurdles, and future directions. [12522434] Cancer Gene Ther 9(12): 959-60 (2002)
2002 56	Viruses as gene delivery vectors: application to gene function, target validation, and assay development. [12136431] Cancer Gene Ther 9(8): 692-9 (2002)
2000 57	Adenovirus as a gene therapy vector for hematopoietic cells. [10880011] Cancer Gene Ther 7(6): 816-25 (2000)
1999 58	Development and application of adenoviral vectors for gene therapy of cancer. [10195879] Cancer Gene Ther 6(2): 113-38 (1999)
1996 59	Keratinocyte gene transfer and gene therapy. [8909878] Crit Rev Oral Biol Med 7(3): 204-21 (1996)
2008 60	Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. [18558618] Nucleic Acids Res 36(12): 4158-71 (2008)
2000 61	Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications. [10661569] Stem Cells 18(1): 19-39 (2000)
1997 62	Gene transfer into hematopoietic cells. [9368332] Stem Cells 15 Suppl 1(-): 123-34 (1997)
2005 63	Nonviral gene transfer to skeletal, smooth, and cardiac muscle in living animals. [16002623] Am J Physiol Cell Physiol 289(2): C233-45 (2005)
2007 64	The problem of passenger genes in transgenic mice. [17690316] Arterioscler Thromb Vasc Biol 27(10): 2100-3 (2007)
1999 65	Vascular gene transfer : from bench to bedside. [9974398] Arterioscler Thromb Vasc Biol 19(2): 196-207 (1999)
1999 66	Gene therapy for rheumatic diseases. [9920008] Arthritis Rheum 42(1): 1-16 (1999)
2008 67	Development of gene therapy for blood disorders. [18441245] Blood 111(9): 4431-44 (2008)
1999 68	Gene transfer by adenovectors. [10590039] Blood 94(12): 3965-7 (1999)
1997 69	Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders. [9236634] Brain 120 ( Pt 7)(-): 1245-59 (1997)
1997 70	Adenoviral vectors for hepatic gene transfer in animals. [9184566] Chest 111(6 Suppl): 138S-142S (1997)
2008 71	Gene therapy in heart failure. [18566312] Circ Res 102(12): 1458-70 (2008)
2006 72	Induction of HIF-1alpha and iNOS with siRNA: a novel mechanism for myocardial protection. [16397152] Circ Res 98(1): 10-1 (2006)
2001 73	Assessment of risks associated with cardiovascular gene therapy in human subjects. [11532899] Circ Res 89(5): 389-400 (2001)
2007 74	Therapeutic gene regulation: targeting transcription. [17353455] Circulation 115(10): 1180-3 (2007)
2006 75	Large animal models and gene therapy. [16333317] Eur J Hum Genet 14(3): 266-72 (2006)
2001 76	The promise and potential hazards of adenovirus gene therapy. [11302979] Gut 48(5): 733-6 (2001)
1997 77	Gene delivery to the epidermis. [9300669] Hum Mol Genet 6(10): 1761-7 (1997)
1993 78	Transgenesis in nonmurine species. [8406669] Hypertension 22(4): 630-3 (1993)
2000 79	Renal transfer of genetically engineered cells. [11065349] J Am Soc Nephrol 11 Suppl 16(-): S154-8 (2000)
2000 80	Critical aspects of viral vectors for gene transfer into the kidney. [11065348] J Am Soc Nephrol 11 Suppl 16(-): S149-53 (2000)
2002 81	Gene electrotransfer: potential for gene therapy of renal diseases. [11841610] Kidney Int 61(1 Suppl): S37-41 (2002)
2002 82	New generation adenoviral vectors improve gene transfer by coxsackie and adenoviral receptor-independent cell entry. [11841608] Kidney Int 61(1 Suppl): S24-31 (2002)
2002 83	Recent advances in recombinant adeno-associated virus vector production. [11841606] Kidney Int 61(1 Suppl): S9-15 (2002)
2002 84	Herpes simplex virus as a model vector system for gene therapy in renal disease. [11841605] Kidney Int 61(1 Suppl): S3-8 (2002)
1998 85	Strategies of gene transfer to the kidney. [9461084] Kidney Int 53(2): 264-72 (1998)
2005 86	Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy. [15717064] NeuroRx 2(1): 129-38 (2005)
2006 87	Modeling chromosomes in mouse to explore the function of genes, genomic disorders, and chromosomal organization. [16839184] PLoS Genet 2(7): e86 (2006)
2009 88	Well-defined cationic shell crosslinked nanoparticles for efficient delivery of DNA or peptide nucleic acids. [19687218] Proc Am Thorac Soc 6(5): 450-7 (2009)
2000 89	Size does matter: overcoming the adeno-associated virus packaging limit. [11667959] Respir Res 1(1): 16-8 (2000)
2006 90	Gene therapy of liver cancer. [17036377] World J Gastroenterol 12(38): 6085-97 (2006)
2006 91	Ocular gene therapy: a review of nonviral strategies. [17110916] Mol Vis 12(-): 1334-47 (2006)
2004 92	Lentiviral vectors. [15153778] J Biomed Sci 11(4): 439-49 (2004)
2000 93	Adeno-associated virus-based vectors in gene therapy. [10895050] J Biomed Sci 7(4): 279-91 (2000)
2007 94	Combating oncogene activation associated with retrovirus-mediated gene therapy of X-linked severe combined immunodeficiency. [17464421] Braz J Med Biol Res 40(5): 601-13 (2007)
1998 95	Gene therapy: a primer for radiologists. [9821189] Radiographics 18(6): 1343-72 (1998)
1998 96	Vascular gene therapy. [9821188] Radiographics 18(6): 1373-94 (1998)
2003 97	Imaging of vascular gene therapy. [12738874] Radiology 228(1): 36-49 (2003)
2008 98	Physical approaches for nucleic acid delivery to liver. [19083101] AAPS J 10(4): 589-95 (2008)
2007 99	Vectors for airway gene delivery. [17408235] AAPS J 9(1): E11-7 (2007)
2007 100	Peptide-guided gene delivery. [17408236] AAPS J 9(1): E18-29 (2007)
2009 101	Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus. [19194803] AAPS J 11(1): 65-77 (2009)
2005 102	DNA-based therapeutics and DNA delivery systems: a comprehensive review. [16146351] AAPS J 7(1): E61-77 (2005)
2009 103	Nonviral gene delivery: principle, limitations, and recent progress. [19834816] AAPS J 11(4): 671-81 (2009)
2009 104	Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation. [19132538] AAPS J 11(1): 23-30 (2009)
2010 105	Nonviral gene transfer as a tool for studying transcription regulation of xenobiotic metabolizing enzymes. [20713102] Adv Drug Deliv Rev 62(13): 1250-6 (2010)
2009 106	Lentiviral delivery of short hairpin RNAs. [19341774] Adv Drug Deliv Rev 61(9): 732-45 (2009)
2009 107	Antioxidant enzyme gene transfer for ischemic diseases. [19233238] Adv Drug Deliv Rev 61(4): 351-63 (2009)
2009 108	Transcriptional targeting of tumor endothelial cells for gene therapy. [19393703] Adv Drug Deliv Rev 61(7-8): 542-53 (2009)
2008 109	Multilayered polyelectrolyte assemblies as platforms for the delivery of DNA and other nucleic acid-based therapeutics. [18395291] Adv Drug Deliv Rev 60(9): 979-99 (2008)
2003 110	Fratricidal retroviruses: a new twist in gene therapy. [12673128] Cancer Biol Ther 2(1): 100-2 (2003)
2007 111	Radiation to control transgene expression in tumors. [17611403] Cancer Biol Ther 6(7): 1005-12 (2007)
2005 112	Achieving hypoxia-inducible gene expression in tumors. [15846086] Cancer Biol Ther 4(4): 359-64 (2005)
2003 113	Gene therapy for psychiatric disorders. [12562564] Am J Psychiatry 160(2): 208-20 (2003)
2010 114	Lentiviral vectors in gene therapy: their current status and future potential. [20143172] Arch Immunol Ther Exp (Warsz) 58(2): 107-19 (2010)
2010 115	The role of liver sinusoidal cells in hepatocyte-directed gene transfer. [19948827] Am J Pathol 176(1): 14-21 (2010)
2003 116	Primer on medical genomics. Part X: Gene therapy. [14601696] Mayo Clin Proc 78(11): 1370-83 (2003)
2005 117	Pulsed high-intensity focused ultrasound enhances systemic administration of naked DNA in squamous cell carcinoma model: initial experience. [15798154] Radiology 235(2): 541-6 (2005)
2006 118	Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo. [17057369] J Biomed Biotechnol 2006(4): 71659 (2006)
2010 119	Exon skipping with morpholino oligomers: new treatment option for cardiomyopathy in Duchenne muscular dystrophy? [20008475] Cardiovasc Res 85(3): 409-10 (2010)
2009 120	Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells. [19471016] Blood 114(8): 1461-8 (2009)
2010 121	Gene therapy for vision loss -- recent developments. [21122474] Discov Med 10(54): 425-33 (2010)
2009 122	Viral vectors: from virology to transgene expression. [18776913] Br J Pharmacol 157(2): 153-65 (2009)
2009 123	Physical methods of nucleic acid transfer: general concepts and applications. [19154421] Br J Pharmacol 157(2): 207-19 (2009)
2003 124	Targeted genetic repair: an emerging approach to genetic therapy. [12897195] J Clin Invest 112(3): 310-1 (2003)
2003 125	Ribozyme-mediated revision of RNA and DNA. [12897196] J Clin Invest 112(3): 312-8 (2003)
2003 126	Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing. [12925685] J Clin Invest 112(4): 474-80 (2003)
2003 127	The potential for gene repair via triple helix formation. [12925687] J Clin Invest 112(4): 487-94 (2003)
2007 128	Meganuclease and transposon mediated transgenesis in medaka. [18047687] Genome Biol 8 Suppl 1(-): S10 (2007)
2007 129	Manipulating the Xenopus genome with transposable elements. [18047688] Genome Biol 8 Suppl 1(-): S11 (2007)
2007 130	Predicting preferential DNA vector insertion sites: implications for functional genomics and gene therapy. [18047689] Genome Biol 8 Suppl 1(-): S12 (2007)
2007 131	Pigs taking wing with transposons and recombinases. [18047690] Genome Biol 8 Suppl 1(-): S13 (2007)
2004 132	Lentiviral transgene vectors. [14710182] EMBO Rep 5(1): 28-9 (2004)
2007 133	Toward reprogramming bacteria with small molecules and RNA. [17967431] Curr Opin Chem Biol 11(6): 612-9 (2007)
2011 134	Gammaretroviral vectors: biology, technology and application. [21994751] Viruses 3(6): 677-713 (2011)
2011 135	The inside out of lentiviral vectors. [22049307] Viruses 3(2): 132-59 (2011)
2011 136	Retroviral vectors: post entry events and genomic alterations. [21994741] Viruses 3(5): 429-55 (2011)
2010 137	Serotype chimeric human adenoviruses for cancer gene therapy. [21994616] Viruses 2(10): 2196-212 (2010)
2010 138	Development of viral vectors for use in cardiovascular gene therapy. [21994642] Viruses 2(2): 334-71 (2010)
2010 139	PEGylated Adenoviruses: From Mice to Monkeys. [21994645] Viruses 2(2): 468-502 (2010)
2008 140	Gene therapy using adeno-associated virus vectors. [18854481] Clin Microbiol Rev 21(4): 583-93 (2008)
2003 141	Harnessing apoptosis for improved anticancer gene therapy. [14695163] Cancer Res 63(24): 8563-72 (2003)
2004 142	Gene therapy in clinical medicine. [15466989] Postgrad Med J 80(948): 560-70 (2004)
2004 143	Lentiviral vectors for the central nervous system. [15520640] MedGenMed 6(3): 17 (2004)
2010 144	Transfection techniques for neuronal cells. [20445041] J Neurosci 30(18): 6171-7 (2010)
2011 145	Application of magnetic nanoparticles to gene delivery. [21747701] Int J Mol Sci 12(6): 3705-22 (2011)
2008 146	Recent developments in peptide-based nucleic acid delivery. [19325804] Int J Mol Sci 9(7): 1276-320 (2008)
2009 147	RNAi nanoparticles in the service of personalized medicine. [19958219] Nanomedicine (Lond) 4(8): 853-5 (2009)
2010 148	Cellular endocytosis and gene delivery. [20454523] Mol Med 16(5-6): 222-9 (2010)
2010 149	Single cell optical transfection. [20064901] J R Soc Interface 7(47): 863-71 (2010)
2011 150	The challenge for gene therapy: innate immune response to adenoviruses. [21399236] Oncotarget 2(3): 113-21 (2011)
2010 151	Delivering the code: polyplex carriers for deoxyribonucleic acid and ribonucleic acid interference therapies. [20032060] Endocrinology 151(2): 466-73 (2010)
2011 152	Novel approaches to in vitro transgenesis. [21134989] J Endocrinol 208(3): 193-206 (2011)
2011 153	The potential of virus-based gene therapies for treatment of metastatic kidney cancer. [21707273] Expert Rev Anticancer Ther 11(6): 809-11 (2011)
2007 154	The state of the art of adeno-associated virus-based vectors in gene therapy. [17939872] Virol J 4(-): 99 (2007)
2010 155	RNA-targeted splice-correction therapy for neuromuscular disease. [20150322] Brain 133(Pt 4): 957-72 (2010)
2003 156	Generating and manipulating transgenic animals using transposable elements. [14613544] Reprod Biol Endocrinol 1(-): 80 (2003)
2003 157	Specific genetic modifications of domestic animals by gene targeting and animal cloning. [14614774] Reprod Biol Endocrinol 1(-): 103 (2003)
2007 158	Live and let die: in vivo selection of gene-modified hematopoietic stem cells via MGMT-mediated chemoprotection. [17482893] DNA Repair (Amst) 6(8): 1210-21 (2007)
2007 159	Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells. [17482894] DNA Repair (Amst) 6(8): 1187-96 (2007)
2011 160	Innate Immune Responses to AAV Vectors. [21954398] Front Microbiol 2(-): 194 (2011)
2011 161	Immunity and AAV-Mediated Gene Therapy for Muscular Dystrophies in Large Animal Models and Human Trials. [21980317] Front Microbiol 2(-): 201 (2011)
2011 162	Hydrodynamic gene delivery and its applications in pharmaceutical research. [21191634] Pharm Res 28(4): 694-701 (2011)
2011 163	Barriers to non-viral vector-mediated gene delivery in the nervous system. [21225319] Pharm Res 28(8): 1843-58 (2011)
2010 164	Pseudovirions as vehicles for the delivery of siRNA. [19998056] Pharm Res 27(3): 400-20 (2010)
2007 165	Delivery of nucleic acids. [17562145] Pharm Res 24(8): 1561-3 (2007)
2008 166	Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer. [17763830] Pharm Res 25(3): 489-99 (2008)
2008 167	Nonviral approaches for neuronal delivery of nucleic acids. [17932730] Pharm Res 25(5): 983-98 (2008)
2007 168	Principles of gene therapy. [17938498] Indian J Dent Res 18(4): 196-200 (2007)
2011 169	Perinatal gene transfer to the liver. [21774770] Curr Pharm Des 17(24): 2528-41 (2011)
2010 170	Development of non-viral vector for cancer gene therapy. [20606371] Yakugaku Zasshi 130(7): 917-23 (2010)
2010 171	Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS. [19840853] Pharmacol Res 61(1): 14-26 (2010)
2008 172	Development and evaluation of a novel gene delivery vehicle composed of adenovirus serotype 35. [18827334] Biol Pharm Bull 31(10): 1819-25 (2008)
2004 173	Recent advances in liver-directed gene transfer vectors. [15313663] Hepatobiliary Pancreat Dis Int 3(3): 332-6 (2004)
2002 174	Development of gene therapy for hematopoietic stem cells using lentiviral vectors. [11960333] Leukemia 16(4): 563-9 (2002)
2010 175	Nanoparticle-mediated interleukin-12 cancer gene therapy. [21092717] J Pharm Pharm Sci 13(3): 472-85 (2010)
2011 176	Integrin targeted delivery of gene therapeutics. [21547161] Theranostics 1(-): 211-9 (2011)
2010 177	Electrostatic surface modifications to improve gene delivery. [20201712] Expert Opin Drug Deliv 7(4): 535-50 (2010)
2009 178	Gene therapy in thalassemia and hemoglobinopathies. [21415990] Mediterr J Hematol Infect Dis 1(1): e2009008 (2009)
2009 179	Nonviral methods for siRNA delivery. [19115957] Mol Pharm 6(3): 651-8 (2009)
2009 180	Biological barriers to therapy with antisense and siRNA oligonucleotides. [19397332] Mol Pharm 6(3): 686-95 (2009)
2010 181	Nano-vectors for the Ocular Delivery of Nucleic Acid-based Therapeutics. [21969738] Indian J Pharm Sci 72(6): 675-88 (2010)
2010 182	Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells). [19830583] Cell Biol Toxicol 26(1): 1-20 (2010)
2009 183	Versatile somatic gene transfer for modeling neurodegenerative diseases. [19669852] Neurotox Res 16(3): 329-42 (2009)
2005 184	RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy. [16430131] J Nanosci Nanotechnol 5(12): 1964-82 (2005)
2011 185	Polymers in small-interfering RNA delivery. [21749290] Nucleic Acid Ther 21(3): 133-47 (2011)
2011 186	Development of viral vectors for gene therapy for chronic pain. [22110937] Pain Res Treat 2011(-): 968218 (2011)
2008 187	Transgenesis procedures in Xenopus. [18699776] Biol Cell 100(9): 503-21 (2008)
2010 188	Progress and prospects: immune responses to viral vectors. [19907498] Gene Ther 17(3): 295-304 (2010)
2008 189	Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production. [17916354] Exp Neurol 209(1): 58-71 (2008)
2010 190	Nanoparticles for retinal gene therapy. [20452457] Prog Retin Eye Res 29(5): 376-97 (2010)
2010 191	Gene delivery to cornea. [19560524] Brain Res Bull 81(2-3): 256-61 (2010)
2011 192	Advancements in adeno-associated viral gene therapy approaches: exploring a new horizon. [21941595] F1000 Med Rep 3(-): 17 (2011)
2007 193	Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA. [17670766] Brief Funct Genomic Proteomic 6(2): 112-9 (2007)
2010 194	Update on gene therapy for immunodeficiencies. [20071242] Clin Immunol 135(2): 247-54 (2010)
2010 195	Hybrid lentiviral vectors. [20407425] Mol Ther 18(7): 1263-7 (2010)
2010 196	Recognition of virus infection and innate host responses to viral gene therapy vectors. [20551916] Mol Ther 18(8): 1422-9 (2010)
2009 197	Orthopedic gene therapy in 2008. [19066598] Mol Ther 17(2): 231-44 (2009)
2010 198	A transposon and transposase system for human application. [20104209] Mol Ther 18(4): 674-83 (2010)
2010 199	Recent advances in lentiviral vector development and applications. [20087315] Mol Ther 18(3): 477-90 (2010)
2009 200	Biological gene delivery vehicles: beyond viral vectors. [19277019] Mol Ther 17(5): 767-77 (2009)
2009 201	MicroRNAs and the regulation of vector tropism. [19107117] Mol Ther 17(3): 409-16 (2009)
2009 202	Progress in genetic therapy for severe combined immunodeficiency associated with adenosine deaminase deficiency. [19337228] Mol Ther 17(4): 577-8 (2009)
2009 203	Integration-deficient lentiviral vectors: a slow coming of age. [19491821] Mol Ther 17(8): 1316-32 (2009)
2009 204	New insights on adenovirus as vaccine vectors. [19513019] Mol Ther 17(8): 1333-9 (2009)
2002 205	Gene repair and transposon-mediated gene therapy. [11897868] Stem Cells 20(2): 105-18 (2002)
2010 206	Cell and gene therapies: moving from research to clinic. [20350323] J Transl Med 8(-): 31 (2010)
2008 207	Development of lentiviral gene therapy for Wiskott Aldrich syndrome. [18194074] Expert Opin Biol Ther 8(2): 181-90 (2008)
2009 208	Foamy virus vectors for gene transfer. [19743892] Expert Opin Biol Ther 9(11): 1427-36 (2009)
2003 209	Transcriptionally targeted gene therapy to detect and treat cancer. [14557054] Trends Mol Med 9(10): 421-9 (2003)
2011 210	Current advances in retroviral gene therapy. [21453283] Curr Gene Ther 11(3): 218-28 (2011)
2011 211	Gene therapy and targeted toxins for glioma. [21453286] Curr Gene Ther 11(3): 155-80 (2011)
2009 212	Immunomodulatory gene therapy in lysosomal storage disorders. [19807648] Curr Gene Ther 9(6): 503-10 (2009)
2007 213	Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions. [17979681] Curr Gene Ther 7(5): 347-60 (2007)
2007 214	Gene therapy for type I glycogen storage diseases. [17430128] Curr Gene Ther 7(2): 79-88 (2007)
2006 215	Regulatable gene expression systems for gene therapy. [16918333] Curr Gene Ther 6(4): 421-38 (2006)
2010 216	Lentiviral vectors for immune cells targeting. [20085508] Immunopharmacol Immunotoxicol 32(2): 208-18 (2010)
2007 217	Lentiviral vectors: are they the future of animal transgenesis? [17684037] Physiol Genomics 31(2): 159-73 (2007)
2010 218	Cardiac gene therapy: optimization of gene delivery techniques in vivo. [19947886] Hum Gene Ther 21(4): 371-80 (2010)
2009 219	Immune responses to herpesviral vectors. [19216681] Hum Gene Ther 20(5): 434-41 (2009)
2009 220	Large-scale adeno-associated viral vector production using a herpesvirus-based system enables manufacturing for clinical studies. [19569968] Hum Gene Ther 20(8): 796-806 (2009)
2009 221	Producing recombinant adeno-associated virus in foster cells: overcoming production limitations using a baculovirus-insect cell expression strategy. [19604040] Hum Gene Ther 20(8): 807-17 (2009)
2008 222	Molecular engineering of viral gene delivery vehicles. [18647114] Annu Rev Biomed Eng 10(-): 169-94 (2008)
2003 223	Current status of gene therapy for inherited lung diseases. [12524461] Annu Rev Physiol 65(-): 585-612 (2003)
2009 224	Methods, potentials, and limitations of gene delivery to regenerate central nervous system cells. [19707413] Biologics 3(-): 245-56 (2009)
2011 225	Research progress on siRNA delivery with nonviral carriers. [21720513] Int J Nanomedicine 6(-): 1017-25 (2011)
2009 226	Transposon-mediated genome manipulation in vertebrates. [19478801] Nat Methods 6(6): 415-22 (2009)
2002 227	Using nuclear targeting signals to enhance non-viral gene transfer. [11940112] Immunol Cell Biol 80(2): 119-30 (2002)
2008 228	Nonviral gene transfection nanoparticles: function and applications in the brain. [18313990] Nanomedicine 4(2): 89-97 (2008)
2010 229	Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures. [20143927] Tissue Eng Part B Rev 16(1): 13-20 (2010)
2009 230	Adeno-associated virus vector integration. [19649989] Curr Opin Mol Ther 11(4): 442-7 (2009)
2008 231	Nonviral ocular gene therapy: assessment and future directions. [18830921] Curr Opin Mol Ther 10(5): 456-63 (2008)
2007 232	Bioconjugation of oligonucleotides for treating liver fibrosis. [18154454] Oligonucleotides 17(4): 349-404 (2007)
2010 233	Development of recombinant cationic polymers for gene therapy research. [20399239] Adv Drug Deliv Rev 62(15): 1524-9 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Gene transfer.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Gene transfer.php on line 92